Fast label-free live imaging with FlowVision reveals key principles of cancer cell arrest on endothelial monolayers
EMBO J. 2026 Jan 6. doi: 10.1038/s44318-025-00678-9. Online ahead of print.
Published on January 6, 2026
ABSTRACT
The rapid, transient, and unpredictable nature of interactions between circulating cells and the endothelium challenges the investigation of these events under flow conditions. Here, we developed an imaging and image-analysis framework called FlowVision, which integrates fast, bright-field live-cell imaging with deep-learning-based image analysis to quantitatively track cell landing and arrest on an endothelial monolayer under physiological flow conditions. Using FlowVision, we find that pancreatic ductal adenocarcinoma (PDAC) cells exhibit variable adhesion strength and flow sensitivity. Remarkably, some PDAC cells demonstrate comparable endothelial engagement to leukocytes, preferentially arresting at endothelial junctions, providing them access to the underlying basal extracellular matrix. PDAC cells attach and form clusters in areas with high expression of the endothelial CD44 receptor. Targeting CD44 using siRNA, function-blocking antibodies, or degrading its ligand, hyaluronic acid (HA), strongly reduces PDAC cell attachment. Overall, our label-free live-imaging approach demonstrates that cancer and immune cells share both common and unique features in endothelial adhesion under flow, and allows identification of CD44 and HA as key mediators of PDAC cell arrest.
PMID:41495248 | DOI:10.1038/s44318-025-00678-9
Latest Publications
- The inflammatory path toward type 1 diabetes begins during pregnancy
- Single-cell RNA-seq analysis of longitudinal CD4+ T cell samples reveals cell-type-specific changes during early stages of type 1 diabetes
- Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies
- PhotoFiTT: a quantitative framework for assessing phototoxicity in live-cell microscopy experiments
- A resource to empirically establish drug exposure records directly from untargeted metabolomics data